IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous system by unknown
RESEARCH Open Access
IL-33 signaling is essential to attenuate
viral-induced encephalitis development by
downregulating iNOS expression in the
central nervous system
Rafael F. O. Franca1*†, Renata S. Costa2†, Jaqueline R. Silva2, Raphael S. Peres2, Leila R. Mendonça1, David F. Colón2,
José Carlos Alves-Filho3 and Fernando Q. Cunha3*
Abstract
Background: Viral encephalitis is a common cause of lethal infections in humans, and several different viruses are
documented to be responsible. Rocio virus is a flavivirus that causes a severe lethal encephalitis syndrome in
humans and also mice, providing an interesting model to study the CNS compartmentalized immune response.
Interleukin 33 (IL-33), a member of the IL-1 family, is an immunomodulatory cytokine that is highly expressed in the
CNS. However, the role of IL-33 on viral encephalitis remains unclear. Therefore, we aimed to explore how the
IL-33/ST2 axis regulates the local immune response during Rocio virus infection.
Methods: Wild-type (WT), ST2 (ST2−/−), and nitric oxide synthase-deficient mice (iNOS−/−) and Stat6 (Stat6−/−)-deficient
mice were infected with different concentrations of the Rocio virus by intraperitoneal route, the cytokine mRNA level in
CNS was analyzed by qPCR, and cellular immunophenotyping was performed on infected mice by the flow cytometry
of isolated CNS mononuclear cells.
Results: We have shown that the mRNA expression of IL-33 and ST2 receptors is increased in the CNS of Rocio
virus-infected WT mice and that ST2−/− mice showed increased susceptibility to infection. ST2 deficiency was correlated
with increased tissue pathology, cellular infiltration, and tumor necrosis factor alpha (TNF-α) and interferon-gamma
(IFN-γ) mRNA levels and higher viral load in the CNS, compared with wild-type mice. The increased Th1 cytokine levels
released in the CNS acted on infiltrating macrophages, as evidenced by flow cytometry characterization of cellular
infiltrates, inducing the expression of iNOS, contributing to brain injury. Moreover, iNOS−/− mice were more
resistant to Rocio virus encephalitis, presenting a lower clinical score and reduced mortality rate, despite the
increased tissue pathology.
Conclusions: We provide evidences of a specific role for IL-33 receptor signaling in nitric oxide induction
through local IFN-γ modulation, suggesting that nitric oxide overproduction might have an important role in
the progression of experimental viral encephalitis.
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Background
The Rocio virus (ROCV), member of the Flaviviridae
family with some well-known viruses, such as West Nile,
dengue, yellow fever, and more recently Zika, is a single-
stranded RNA virus that infects humans and other
vertebrates. Infection with ROCV leads to a wide range
of symptoms including, but not restrict to, the following:
fever, headache, anorexia, nausea, vomiting, myalgia, and
malaise. The pathology of this viral infection in humans
ranges from asymptomatic to acute encephalitis [1]. Pre-
vious studies from our group demonstrated that ROCV
infects and induces in BALB/c mice damage of the
central nervous system (CNS), characterized by neuronal
degeneration and apoptosis with detectable levels of
inflammatory cytokines and massive cellular infiltration [2].
Moreover, cellular infiltration in CNS is highly dependent
of the CCR-5/MIP-1α axis, since CCR5 and macrophage
inflammatory protein 1 alpha (MIP-1α) knockout mice
presented reduced inflammation with increased survival
rates after ROCV infection [3]. CNS cellular infiltration
induced by ROCV infection is characterized by F4/80+
cells, detected early as 4 days post-infection. At later points
after infection, the CNS became infiltrated with NK, B cells,
and especially T lymphocytes. Locally, these cells produce
high amounts of interferon-gamma (IFN-γ) and tumor
necrosis factor alpha (TNF-α), among other cytokines,
which contribute to the degeneration and death of neurons
with extensive tissue damage [2].
Interleukin 33 (IL-33), a member of the IL-1 cytokine
family, is constitutively expressed by tissue barrier cells
such as the epithelial and endothelial cells of different
body compartments. In addition, some innate immune
cells such as macrophages and dendritic cells also ex-
press IL-33 [4–6]. IL-33 is recognized as the functional
ST2 receptor ligand, a heterodimer receptor complex
consisting of ST2 and the IL-1 receptor accessory
protein (IL-1RAcP) [4]. ST2 cell surface expression is
observed on T helper 2 (Th2) cells but not on T helper
(Th1) cells; thus, it functions as an important effector
molecule of T helper type 2 responses [7]. ST2 activation
signals through the myeloid differentiation primary re-
sponse gene 88 (MyD88) and nuclear factor kappa b (NF-
kB) pathway, inducing the production of several cytokines
and chemokines. Moreover, ST2 activation causes cell
differentiation, polarization, and activation, depending on
the target cell [5].
On viral and parasitic experimental infections, IL-33
plays a crucial role in the local immune response to
several different pathogens [8–11]. In fact, it has been
reported that in mice, IL-33 is necessary for effective
cluster of differentiation 8 (CD8+) T cell responses to
replicate lymphocytic choriomeningitis virus (LCMV),
an RNA virus, and against murine γ-herpesvirus 68
(MHV-68), a DNA virus. Interestingly, recombinant IL-33
administration improved vaccine-induced CD8+ T cell
responses to vaccinia virus-based vectors and virus-like
particles (VLPs) [12]. Following infection with coxsackie-
virus B (CVB), mice deficient for T1/ST2 (IL-33R signal-
ing) significantly developed more severe pancreatitis with
greater weight loss and higher viral load compared with
wild type [8]. However, the role of IL-33 in the ROCV-
induced host CNS-damage was not addressed yet. In
human, rhinovirus infection induced asthma exacerbation
dependent of IL-33 and the production of type 2 cytokines
IL-4, IL-5, and IL-13. The authors state that IL-33 induc-
tion directly correlates with viral load and IL-5 and IL-13
levels, proposing IL-33 inhibition as a novel therapeutic
approach for virus-induced asthma exacerbations [13].
However, depending on the organ involved and the Th1/
Th2 immune balance necessary to control the infection,
IL-33 may also present opposing roles.
Herein, we are showing that the ST2 receptor is
expressed in the CNS during experimental murine ROCV-
induced encephalitis. The ST2 deficiency, by target
disruption in BALB/c mice (T1/ST2−/−), led to im-
paired control of viral burden in the CNS, which was
associated with an early cellular CNS infiltration and
a Th1-polarized immune response with consequent
increased expression of the cytokines TNF-α and
IFN-γ, which in turn upregulates tissue inducible ni-
tric oxide synthase (iNOS) expression. In the brain,
the generation of reactive nitrogen species through
iNOS induction could act by increasing the oxidative
stress responsible for tissue injury, worsening the
disease. In conclusion, our data suggest that IL-33
might play a crucial role in the pathogenesis of virus-
induced encephalitis by controlling the local Th1/Th2
balance.
Results
BALB/c mice are susceptible to ROCV infection
First, we assessed the susceptibility of BALB/c by
infecting these animals with different concentrations
of the Rocio virus (ROCV) by intraperitoneal (i.p.)
route. By 9 days after i.p. inoculation, 1.106 plaque-
forming unit (PFU) ROCV-infected mice experienced
100 % mortality; in contrast, 1.105 PFU ROCV-
infected mice showed a reduced and delayed mortal-
ity. The peak of mortality was 70 % which was
reached at 11 days post-infection (Fig. 1a). There are
no differences on weight change on mice infected
with 1.106 or 1.105 PFU (Fig. 1b); however, higher
titer-infected mice displayed an earlier development
of encephalitis signals, as determined by clinical score
(Fig. 1c). We also recovered increased tissue virus
concentrations on higher titer-infected mice, since
this group presented a higher viral load on the brain,
when compared to low titer infection (Fig. 1d).
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Infected BALB/c mice display high cell infiltration and
cytokine production in the CNS
In two previous studies, we characterized partially the
immune response to ROCV infection [2, 3]. Here, to
better understand the immunopathologic process, we
infected BALB/c mice with 1.106 PFU ROCV, sacrificed
these animals at 5 and 7 days post-infection (p.i.) (when
encephalitis symptoms are evident) and analyzed the
profile of cell infiltration in the CNS by fluorescent-
activated cell sorting (FACS). We observed an increased
cellular infiltration on CNS, characterized mainly by
CD3− cells at 5 and 7 days p.i. (Fig. 2a). In the cellular
infiltrates, it was also demonstrated the presence of
CD3+ cells (Fig. 2b), constituted in its majority by
CD3+CD8+ cells and fewer CD3+CD4+ cells, and these
infiltrates were significantly higher at 7 days p.i., coincid-
ing with disease peak and clinical symptom appearance
(Fig. 2c). Next, we analyzed the kinetics of the local
immune response by quantifying the messenger ribo-
nucleic acid (mRNA) expression level of T helper subtype
signature cytokines IFN-γ and IL-17A and the pro-
inflammatory cytokine TNF-α, in the CNS of ROCV-
infected mice. The TNF-α mRNA level was significantly
increased at 5 days p.i., reaching an even higher level by
7 days p.i. (Fig. 2d). At 7 days p.i., we observed a massive
expression of IFN-γ mRNA (Fig. 2e), coinciding with the
appearance of CD3+ on the CNS tissue (Fig. 2b, c) and
signs of disease. As expected, the IL-17A cytokine (Fig. 2f)
was not significantly altered on ROCV-infected animals,
when compared to mock-infected animals.
IL-33 is expressed by CNS-infiltrating F4/80+ cells
To further characterize the immune response to ROCV
infection, we evaluated the expression levels of IL-33
and the levels of mRNA from ST2L (transmembrane
form) receptor on CNS cells isolated from ROCV-
infected animals. As observed in Fig. 3a, wild-type (WT)
BALB/c infected with a lethal dose of ROCV (1.106
PFU) had an increased infiltration of F4/80+ cells on
CNS at 7 days post-infection. When we analyzed the
levels of IL-33 expression by F4/80+ cells isolated from
the CNS, we found increased IL-33 production following
ROCV infection at day 7 (Fig. 3a). Moreover, a kinetic
analysis of IL-33 and ST2L receptor mRNA levels on
CNS-isolated cells from 1.106 PFU ROCV-infected mice
demonstrated a significant IL-33 response at day 5 post-
infection and ST2L receptor upregulation at 5 and 7 days
following infection (Fig. 3b, c).
Fig. 1 BALB/c mice are susceptible to ROCV infection. a Groups of ten female 6-week-old BALB/c (WT) mice were infected intraperitoneally (i.p.)
with either 1.105 or 1.106 PFU of ROCV and monitored daily for survival up to 21 days post-infection. b Infected mice were monitored daily for
weight loss after infection. c Clinical score of ROCV-infected mice, evaluated as described in the “Methods” section. d The viral load on the brains
of infected mice was assessed by real-time qPCR on days 5, 7, and 15 post-infection. Animals were infected with 1.105 or 1.106 PFU of ROCV as
indicated. Results are representative of the mean of ten animals per group. ND not determined
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Fig. 2 Inflammatory profile in the brain of ROCV-infected BALB/c mice. a Number of CD3− cells in the brain after 5 or 7 days of infection with
ROCV 1.106 PFU analyzed by FACS. b Number of CD3+ cells after ROCV infection as indicated. c Number of CD4+- and CD8+-infiltrating cells in
the brain after 7 days post-infection (disease peak) with ROCV 1.106 PFU, gated on CD3+ cells. d Expression levels of TNF-α mRNA in the
brain of mice infected with ROCV 1.106 PFU 5 and 7 days post-infection, analyzed by qPCR. e qPCR of IFN-γ mRNA expression in the
brains of ROCV-infected mice. f IL-17A mRNA expression. *p < 0.05, **p < 0.001 or ***p < 0.0001. NS non-significant. Data are representative
as the mean of three independent experiments with at least four animals per group. Statistical analysis was performed by Student t test
using the software GraphPad Prism
Fig. 3 IL-33 expression in CNS-infiltrating cells. a Frequency of F4/80+ cells in the CNS of false infected WT mouse (WT mock), analyzed by FACS.
Frequency of F4/80+ cells isolated from 1.106 PFU ROCV-infected mouse 7 days after infection. (WT 7 days p.i.) Expression of IL-33 on F4/80+ gated
cells isolated from CNS of mock and 1.106 PFU ROCV-infected mouse, analyzed by flow cytometry—FACS. Dots are representative from a single
animal (with at least three animals per group). b, c Expression levels of IL-33 and ST2L (transmembrane form) mRNA in the brain of mice infected
with ROCV 1.106 PFU, analyzed by qPCR. Data are representative as the mean of three independent experiments with at least four animals per
group. Statistical analysis was performed by unpaired Student t test using the software GraphPad Prism
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IL-33 deficiency contributes to viral encephalitis
aggravation
Among several biological activities of IL-33, the promo-
tion of Th2 and inhibition of Th1 responses are well
documented [14]. Here, given the strong upregulation of
IL-1R4/ST2 observed on CNS from ROCV-infected
mice, we aimed to investigate the role of IL-33/ST2
signaling on disease progression. Initially, we infected
WT and ST2−/− mice with different concentrations of
ROCV, and we observed no differences on survival when
the animals were infected with either 1.106 or 1.105 PFU
(data not shown). However, when we infected mice by
intraperitoneal route with a non-lethal dose of ROCV
(1.104 PFU) and compared the disease development on
IL-33 receptor-deficient mouse (ST2−/−) versus WT
mice, we observed that wild-type mice are completely
resistant to ROCV-induced encephalitis development;
on the other hand, ST2−/− mice experienced a 50 %
mortality rate up to 21 days post-infection as observed
in Fig. 4a. Also, ST2−/−-infected mice presented a higher
clinical score beginning as early as 8 days post-infection
(Fig. 4b) and a higher viral load on CNS at 9 days post-
infection (Fig. 4c) with apparent signs of encephalitis
and evident cellular infiltrates at the CNS (Fig. 4g). Next,
to elucidate the role of IL-33 on local cytokine modula-
tion, we evaluated the mRNA expression of the Th2 key
cytokine IL-4 (Fig. 4d) and pro-inflammatory cytokines
IFN-γ (Fig. 4e) and TNF-α (Fig. 4f ) in the CNS and by
enzyme-linked immunosorbent assay (ELISA) on the
serum of infected animals (Fig. 4e, f ). As observed,
ST2−/− mice had higher levels of TNF-α and IFN-γ
transcripts locally (at the CNS) when analyzed 9 days
Fig. 4 IL-33 protects mice from ROCV-induced encephalitis. a Groups of ten female 6-week-old BALB/c (WT) and T1/ST2-deficient mice (ST2−/−)
were infected intraperitoneally (i.p.) with 1.104 PFU of ROCV and monitored daily for survival up to 21 days post-infection. b Clinical score of
ROCV-infected WT and ST2−/− mice. c The viral load on the brains of infected WT and ST2−/− mice was assessed by real-time qPCR on
day 9 post-infection. Expression levels of IL-4 (d), IFN-γ mRNA (e), and TNF-α (f) in the brain of mice infected with ROCV 1.104 PFU 9 days
post-infection, analyzed by qPCR. ELISA quantification of IFN-γ (g) and TNF-α (h) in serum of WT and ST2−/− mice as indicated on the
figure legends. i Histopathological analysis of brain tissues from mock wild type—histopathological score as described in the “Methods”
section. Histologic slides of mock-infected WT (j), 1.104 PFU ROCV-infected wild type (k), mock ST2−/− (l), and 1.104 PFU ROCV-infected
ST2−/− mice (m); all the animals were sacrificed at 9 days post-infection. Magnification ×200. *p < 0.05, **p < 0.001, or # non-significant
compared to WT at 9 days post-infection. Data are representative as the mean of three independent experiments with at least four
animals per group. Statistical analysis was performed by unpaired Student t test using the software GraphPad Prism
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post-infection (when disease symptoms are evident on
ST2−/− mice); systemically (serum cytokines), the pro-
duction of these cytokines were also increased, when
compared to WT mice (Fig. 4g, h).
Histopathological analysis of CNS from mock and
infected animals demonstrated a higher cellular infiltrate
only on ST2−/− animals following 9 days post-infection
(Fig. 4i). Inflammatory cell infiltrates were not observed
in CNS tissues from uninfected animals and the WT
mouse (Fig. 4j–m). The histopathological scores were
higher on the ST2−/−-infected mouse (Fig. 4h). Mono-
nuclear cellular infiltrates were concentrated mainly on
meninges and cortex areas of ST2−/− mice and were
more prominent around blood vessels.
Infiltrating lymphocytes contributes to disease
progression by cytokine production
To better understand the pathogenic mechanism of IL-
33 signaling on ROCV-induced encephalitis, we explored
the cellular composition of CNS tissue and the cytokines
being produced on WT versus ST2−/− mice. FACS
analysis of the CNS tissue 9 days post-infection demon-
strated a cellular infiltrate constituted mainly by CD4+
and CD8+ T cells (Fig. 5a, e). ST2−/−-infected mice had
an increased frequency of both CD4+ and CD8+ T cells;
moreover, only CD3+CD4+ cells produce significantly
higher levels of IFN-γ (Fig. 5c, g) but not TNF-α
(Fig. 5d, h) or IL-10 (Fig. 5d, h) after the infiltrate of
the CNS tissue.
ST2−/− mice show increased iNOS expression in the CNS
following ROCV infection
In this study, we have found a higher proportion of
lymphocytes infiltrating the CNS of ROCV-infected
ST2−/− mice at 9 days post-infection, when the disease is
evident; additionally, these cells appear to contribute to
encephalitis aggravation by producing higher levels of
pro-inflammatory cytokines. Thus, we hypothesized that
the higher amounts of IFN-γ released on ST2−/− CNS
mice could contribute to disease aggravation by shifting
the local immune response to a Th1 profile, inducing a
debalanced Th1/Th2 immune response and tissue dam-
age. On type 2 innate lymphoid cells (ILC2), IL-33 signal-
ing induces the production of Th2 cytokines such as IL-4,
IL-5, and IL-13, leading to M2 macrophage polarization
[15]. To check if the absence of IL-33 signaling could be
affecting macrophage polarization, we evaluated the ex-
pression of the enzyme inducible nitric oxide synthase
(iNOS), which metabolizes arginine to nitric oxide (NO)
and is highly upregulated on M1 macrophages. Also, given
that Stat6 phosphorylation is mediated by IL-4 and that
IL-4-mediated inhibition of iNOS expression on mac-
rophages is Stat6 dependent [16], we investigated the
potential role of Stat6 in ROCV-induced encephalitis.
We analyzed by quantitative polymerase chain reac-
tion (qPCR) the levels of iNOS (M1 macrophage
marker) and arginase-1 (M2 macrophages marker) on
CNS tissue from infected animals; on both groups
(ST2−/−- and Stat6−/−-infected mice), the mRNA levels
Fig. 5 Phenotypic profile of CNS infiltrating cells. BALB/c and ST2−/− mice were infected with 104 PFU of ROCV. CNS infiltrating cells were
collected 9 days post-infection, and stimulated for 4 h with phorbol-12-myristate-13-acetate (PMA) and ionomycin in the presence of brefeldin A.
The frequency of CD3+ and CD4+ or CD8+ T cells (a, e) and IL-10 (b, f), IFN-γ (c, g), and TNF-α (d, h)-producing cells was analyzed by
flow cytometry (FACS). *p < 0.05, **p < 0.001. NS non-significant. Data are representative as the mean of three independent experiments
with at least five animals per group. Statistical analysis was performed by Student t test using the software GraphPad Prism
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for iNOS (Fig. 6a), but not arginase-1 (Fig. 6b), were
significantly upregulated at 9 days post-infection,
compared to WT infected mice. To check which cells
could be contributing to iNOS expression, we per-
formed a FACS analysis of CNS cellular infiltrates.
We observed a higher frequency of CD45+ F4/80+
cells on ST2−/−- and Stat6−/−-infected mice (1.104
PFU) at 9 days post-infection, when compared to WT
mice (Fig. 6c). Moreover, these cells were also ex-
pressing much higher levels of iNOS (Fig. 6d, e),
analyzed by FACS on CNS-isolated CD45+ F4/80+
gated cells. To complement our data, we checked
survival and clinical score of Stat6−/− mice and we
observed similar results to ST2−/−-infected mice, as
well CNS-infiltrating lymphocyte profile and serum
cytokines (Additional file 1: Figures S1 to S4).
Fig. 6 IL-33 and nitric oxide participates on ROCV-induced encephalitis. a iNOS mRNA expression in the brain of WT, ST2−/−- and STAT6−/−-in-
fected mice. b Arg1 mRNA expression in the brain of WT,ST2-/- and STAT6-/- infected and control mice. mRNA expression was determined with
qPCR normalized for the GAPDH CT value. Data are expressed as mean ± SE. c Frequency of F4/80+ cells (gated on CD45+) isolated from brain
tissues of WT, ST2−/− and STAT6−/− 9 days after infection with ROCV. d iNOS expression (gated on CD45+ F4/80+ cells). e Mean fluorescence in-
tensity (MFI) of iNOS+ cells. f Groups of ten female 6-week-old WT or iNOS-deficient mice (iNOS−/−) were infected intraperitoneally with 1.106
PFU of ROCV and monitored daily for survival up to 21 days post-infection. g Clinical score of ROCV-infected mice. Mice were infected with 1.106
PFU of ROCV and sacrificed as indicated. *p < 0.05, **p < 0.001. Statistical analysis was performed by Student t test using the software GraphPad
Prism. Data are representative as the mean of three independent experiments with at least four animals per group
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iNOS deficiency protects mice from lethal viral
encephalitis
Finally, to check the role of NO on ROCV-induced
experimental encephalitis, we infected iNOS−/− and WT
C57BL/6 mice with a lethal dose of ROCV (1.106 PFU)
and monitored survival, clinical score, and tissue path-
ology on these animals. As observed in Fig. 6f, iNOS−/−
mice presented an increased survival rate than wild-type
infected animals. Moreover, iNOS−/− mice were partially
protected from disease as evidenced by the lower clinical
score (Fig. 6g). Interestingly, iNOS−/− mice CNS exhib-
ited abundant cell infiltrates to levels compared to WT
mice (Additional file 1: Figure S5) despite the increased
survival rate.
Discussion
Understanding the pathogenic mechanisms of viral in-
fections in the CNS is critical to encephalitis treatment.
Previous reports demonstrate that CNS IL-33 signaling
is related to protection following experimental infection
with Toxoplasma gondii, and the authors found that IL-
33 deficiency leads to increased parasite burden and
pathology in the brains of infected mice [17]. Here, in
this study, we demonstrate that IL-33 has a protective
role on experimental viral encephalitis. Our data sup-
ports previous studies in the literature demonstrating
the contribution of IL-33 on T cell response modulation
[7, 18]. Here, the absence of ST2 (the receptor for IL-33)
following the infection with an encephalitogenic virus
leads to increased cellular-mediated immunopathology
on mouse CNS.
Although the influenza A virus induced the production
of IL-33 in alveolar macrophages and the activation of
IL-13-producing natural helper cells and that after infec-
tion with coxsackievirus B, IL-33 in the pancreas is
markedly elevated, data about the role of IL-33 signaling
on viral infections are still scarce [8, 19]. Even though
the participation of IL-33 is well documented on several
different pathologies and disease conditions, we are the
first to demonstrate the protective role of IL-33 signaling
on viral experimental encephalitis. We are showing that
IL-33 is expressed on the CNS following infection with a
neurotropic virus, balancing the local immune response
with consequent protection from exacerbated CNS in-
jury. In fact, among other CNS pathologies, Jiang et al.
[20] demonstrated that IL-33 administered after ex-
perimental autoimmune encephalomyelitis (EAE) onset
could be protective against the disease and also that
ST2−/− mice developed exacerbated disease following
EAE induction. Interestingly, recombinant IL-33 treatment
attenuates EAE by suppression of IL-17 and interferon-
gamma (IFN-γ)-producing cells [20]. In addition, it was
recently demonstrated that IL-33 is widely expressed on
the healthy brain, especially by oligodendrocytes and gray
matter astrocytes. Following CNS injury, induced by mech-
anical spinal cord contusion, IL-33 is immediately released
acting on astrocytes and microglia to signal the production
of chemokines that recruit monocytes and enhance M2
genes at the injury site involved in immunosuppression and
tissue repair [21]. Thus, it seems that IL-33 production in
response to CNS injury could represent a protective mech-
anism. In our model, the protective role of IL-33 is directly
related to the local T cell response modulation, since IL-33
deficiency leads to augmented Th1 local immune response,
with IFN-γ overproduction and increased death following
infection with ROCV. In fact, on viral infections, IFN-γ is
important to virus clearance; however, exacerbated IFN-γ
response could lead to tissue damage due to the extensive
inflammation process, as observed in our results.
Given that IL-33 is characterized as a nuclear alarmin
released after the cell is damaged, it is not surprising
that a neurotropic virus such as ROCV could upregulate
IL-33 production. ROCV infection induces degeneration
and neuronal death, and apoptotic cells expressing cas-
pase 3 (mainly neurons, lymphomononuclear and endo-
thelial cells) were significantly increased across different
CNS regions in later time points after ROCV infection.
Viral antigens are usually detected on CNS after 4 days
of infection [2]. In our results, we detected IL-33 expres-
sion also in later time points, coinciding with the detec-
tion of virus replication in the CNS. However, virus
replication itself may not be the only factor inducing cell
damage in the CNS; we suggest that the extensive injury
might actually be a consequence of the inflammation,
characterized by waives of cellular infiltration and local
cytokine production. In this scenario, IL-33 is important
to drive the expression of Th2-type cytokines which in
turn can protect the animals by downregulating the
CNS Th2-type inflammatory response. On the other
hand, Th2 cytokines might not have a direct role on viral
clearance. In fact, on viral infections of the CNS, the
immune responses implicated on viral clearance are
usually cell specific, for example, antibody responses are
important to neurons and the T cell-mediated immune
responses are more important to virus clearance from
glial cells [22]. Upon ROCV infection, a mixed Th1/Th2
immune response is already documented [2]. Thus, it is
crucial to identify specific immune factors that partici-
pate in protective virus response. In our analyses, we
demonstrate a critical protective role of IL-33 signaling
on CNS immune responses. However, the precise me-
chanisms of IL-33 synthesis, localization, and release
during CNS viral inflammation remain to be fully char-
acterized. Although we indentify macrophages express-
ing higher levels of IL-33 after infection, we cannot
exclude that other CNS resident cells such as glial cells
and astrocytes could be the main source of IL-33
production. In fact, it is previously demonstrated that
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astrocytes secrete IL-33 after inflammatory stimulation
with TNF-α in vitro and that damaged neurons actively
secrete IL-33 following EAE [23]. Moreover, it was
recently demonstrated that dendritic cells can produce
IL-33 after engagement of TLR4 and TLR5 receptors,
and this leads to NF-kB activation and IL-33 expression
following microbial stimulus [24]. The authors testify
that the dendritic cell IL-33 could amplify local inflam-
matory response through an autocrine mechanism. More
recently, Kim et al. [25] demonstrated that CD11chi
dendritic cells act on CNS by controlling the activation
and function of infiltrated monocytes. By selective dele-
tion of CD11chi dendritic cells, the authors found
increased viral copies on CNS and death following mice
infection with Japanese encephalitis virus; further ana-
lysis leads to the conclusion that CD11chi-DC cells can
regulate the activation of CD11b+Ly-6Chi monocytes
controlling exacerbated CNS inflammation [25]. In our
study, the participation of dendritic cells was not addressed
and further experiments are necessary to investigate
the role of these cells on viral encephalitis.
Several different neurotropic viruses such as rabies
virus (RABV), Japanese encephalitis virus (JEV), and
West Nile virus (WNV) and more recently Zika virus
present the potential to disrupt the blood brain barrier
(BBB) and establish tissue damage [26–28]. The patho-
genic mechanisms that contribute to BBB disruption are
diverse, and chemokines or inflammatory cytokines such
as IFN-γ, IL-8, TNF-α, and IL-1β can indirectly contribute
[29]. In this context, IFN-γ has an important role. Follow-
ing infection with JEV on the mouse, neutralization of
IFN-γ ameliorated the enhancement of BBB permeability.
However, the administration of IFN-γ-neutralizing anti-
body did not significantly change the viral load on CNS
[27]. Thus, it seems that IFN-γ production on CNS could
act by breaking the BBB allowing or facilitating the infil-
tration and activation of resident cells such as microglia.
Interestingly, microglia activation has been suggested
to be responsible for the progression of neuronal
damage-releasing neurotoxic factors such as TNF-α or
nitric oxide (NO) [30]. In conclusion, given that all
these pro-inflammatory factors are cytotoxic to neurons,
IL-33 signaling on CNS is crucial to balance the
local inflammatory process by avoiding excessive pro-
inflammatory cytokine production, protecting the neurons
from extensive damage. In our model, we observed higher
levels of both mediators: IFN-γ and NO, following infec-
tion of IL-33 signaling-deficient mouse (ST2−/−) with
ROCV. Thus, microglia overactivation through NO pro-
duction could serve to enhance or amplify the neuronal
damage induced by virus replication. Additionally, we
observed a higher viral load on the CNS of ST2−/− mice;
this could be partly explained by the fact that the
IL-33-deficient mouse presented higher frequencies
of cellular infiltrates in the brain (providing more cells that
can be infected). On the other hand, IL-33 signaling is
necessary to generate effective CD8+ T cell responses in
viral and tumor metastatic models [12, 31]. Thus, ineffect-
ive cytotoxic T cell lymphocyte (CTL) response (CTL) by
the lack of IL-33 could favor ROCV replication in our
model, although a more detailed study on CTL function
could provide more solid data.
Numerous pathological conditions such as Alzheimer’s
disease, Parkinson’s disease, and multiple sclerosis are well
known to induce neurodegeneration [32]. The mecha-
nisms of neuroinflammation are dependent on glial cell
activation, which releases a number of neurotoxic factors,
especially nitric oxide species (NOS) and cytokines. In the
CNS, the production of pro-inflammatory molecules re-
sults in apoptosis in various subsets of resident brain cells.
Interestingly, NO has a neuroprotective effect at phy-
siological levels; however, NO becomes harmful if it is
produced in excess, leading to neuronal damage [33]. Usu-
ally, iNOS expression in the CNS is very low and can be
induced in astrocytes or microglial cells following events
such as viral infection. In fact, it has been reported that in
vitro infection of mouse macrophages with ROCV leads
to NO production [34]. Here, the induction of NO release
by virus infection is highly amplified on the ST2−/− mouse
as a direct consequence of augmented Th1 response on
the CNS. This was associated with the increased CNS
infiltration of immune cells, particularly Th1 cells.
Higher levels of IFN-γ can act by shifting infiltrating
macrophages to the M1 phenotype, as evidenced by a
higher expression of iNOS transcripts on infected
mouse CNS. M1 macrophages are cytotoxic and ex-
hibit pro-inflammatory markers, characterized by the
production of pro-inflammatory cytokines and high
levels of reactive oxygen and nitrogen species [35].
Importantly, it was recently reported that the lack of
IL-33 signaling in CNS results in lower levels of infil-
trating neuroprotective M2 macrophages, which, in
turn, leads to impaired recovery after CNS mechanical
injury [21]. Thus, here we provide evidence that
following viral infection, IL-33 is produced in the CNS
to counteract the deleterious effects of pro-inflammatory
cytokines IFN-γ and TNF-α, as well to shift macrophage
response to a M2-protective phenotype.
We previously demonstrated that ROCV infection
results in increasing diffuse neuronal degeneration start-
ing at 4 days post-infection, with positive caspase 3 glial
and neuronal cells at 9 days post-infection [2]. Nitric
oxide production in the CNS is highly toxic to neurons.
Thus, we hypothesized that NO release in the CNS
could represent the most downstream event on IL-33
local response modulation. Another function of NO is to
act as a negative regulator of immune cell trafficking to
the CNS [36]. It is very interesting that the macrophage
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from the M1 phenotype infiltrates injured CNS tissue
via CCL2 signaling through adjacent spinal cord lepto-
meninges; on the other hand, M2 cells came from
monocytes that trafficked through the brain-ventricular
choroid plexus (CP), via the VCAM-1-VLA4 and CD73
mechanism [37]. At the CP, NO inhibits NF-kB/p65
translocation to the nucleus and sequential leukocyte
entry to the CNS [36]. In our results, we observed higher
cellular infiltrates in iNOS−/−-infected mice (Additional
file 1: Figure S5); however, iNOS deficiency results in
increased survival rates following ROCV infection despite
the higher pathological scores. Thus, taken together, our
data support the idea that NO production in the CNS is
the most neurotoxic product.
Conclusions
Taken together, our data indicate a direct role of IL-33
signaling on CNS immunopathology control. The ab-
sence of IL-33 signaling increases the CNS inflammation
by a mechanism dependent on IFN-γ production that
leads to NO production and consequent tissue damage.
Finally, the data presented here may contribute to the
design of new therapies to viral encephalitis based on
the benefits of IL-33 administration or the blockade of
its receptor ST2 to avoid extensive damage elicited by
the immune response to CNS insults.
Methods
Virus
ROCV (SPH34675 strain) was used for mouse infection
and kindly provided by Prof. Dr. Luiz Tadeu M. Figueiredo,
Ribeirão Preto School of Medicine, University of São
Paulo—Brazil. Virus stocks were obtained from the brains
of intracerebrally infected suckling mice. Mouse brains
were aspirated and macerated in phosphate-buffered
saline (PBS) and centrifuged at 500g for 10 min at 4 °C,
and supernatants were collected and stored at −70 °C until
use. Viral stocks were titrated by the plaque-forming unit
(PFU) assay, as previously described [38].
Animal experimentation
Wild-type BALB/c (WT), ST2-deficient (T1/ST2−/−),
and Stat6-deficient (Stat6−/−) mice were infected by
intraperitoneal route with different concentrations of
ROCV stocks, as stated. C57/B6 wild type and iNOS−/−
were infected by intraperitoneal route of ROCV. A mock
control group (false infected) was inoculated with ex-
tracts from uninfected brain in PBS/albumin7.5 % by the
same route, and volume as used for the virus infection
The clinical score was monitored daily, and the animals
were scored accordingly to the following: 0 normal
mouse, no overt signs of disease; 1 limp tail or hind limb
weakness; 2 limp tail and hind limb weakness; 3 partial
hind limb paralysis; 4 complete hind limb paralysis; and
5 moribund state, death by encephalitis (sacrifice for
ethical reasons). Survival was monitored daily up to
21 days. For tissue collection, the animals were sacrificed
on different days post-infection (p.i.) as indicated and
perfused and tissues samples were collected for analysis.
A blood sample was collected to quantify the levels of
serum cytokines by ELISA. The animals were housed at
five per cage with food and water available ad libitum.
All experiments were conducted in accordance with the
prescribed guidelines on experimental animal welfare of
the National Institutes of Health and were approved by
the Ethics Committee of the Ribeirão Preto Medical
School, University of São Paulo.
Histopathological analysis and CNS histologic scores
Histologic scores were performed in the CNS of infected
and control mice at 9 days post-infection. Briefly, ani-
mals were euthanized and perfused, and brain tissue was
removed and fixed in 10 % formaldehyde. Tissues were
dehydrated in graded ethanol and embedded in a 100 %
paraffin block. Serial sections with 5-μm thickness were
prepared and stained with hematoxylin and eosin. Five
to six photos were obtained for each animal. The extent
of meningeal inflammation was assessed and graded as
follows: 0, no inflammation (total absence of inflamma-
tory cells at the meninges area); 1, one cell layer of
inflammation (a single layer of infiltrating cells at the
meninges); 2, two cell layers of inflammation (two cell
layers at the meninges area); 3, three cell layers of
inflammation; 4, four cell layers; and 5, five or more cell
layers of inflammation. The area with the maximal ex-
tent of tissue damage was used for the assessment of
each brain region.
Clinical scores
The clinical score was assessed daily as described by
Miller et al. [39]. Briefly, the following grades were
considered: 0 normal mouse, no signs of disease; 1 limp
tail or hind limb weakness (but not both); 2 limp tail
and hind limb weakness (both symptoms manifestation);
3 partial hind limb paralysis; 4 complete hind limb
paralysis; and 5 moribund state (euthanasia performed
for ethical issues).
Tissue quantification of cytokine mRNAs and viral load
Total RNA from brain samples (approximately 100 mg
from each animal time point) was extracted with the
TRIzol Reagent (Life Technologies, Carlsbad, CA, USA)
according to the manufacturer’s instructions. After ex-
traction, RNA was quantified by absorbance at 260 nm
and approximately 1 μg of each sample was used to
obtain the complementary DNA (cDNA) strands using
the SuperScript III enzyme (Life Technologies) and
Oligo(dT)12-18 for first strand synthesis, according to
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the manufacturer’s instruction. Real-time polymerase
chain reaction (PCR) analysis of cytokine mRNA profiles
was performed with the Power SYBR® Green Master Mix
kit (Applied Biosystems, CA, USA), and reactions were
processed in ABI7500 equipment (Applied Biosystems).
The results were analyzed on the basis of the cycle thresh-
old (Ct) of target genes, and the level of expression was
calculated by comparing to an endogenous control gene
(β-actin) using the ΔΔCt method (relative amount of
target gene for each sample is quantified by the equation
2−ΔΔCt); data were analyzed with the comparative Ct
method. The reactions were carried out in a final vol-
ume of 25 μl containing 12.5 μl of SYBR Green PCR
Master Mix, 0.5 μM of each primer (designed on the
basis of the mRNA sequence of the cytokine genes),
and 5 μl of cDNA. RT-PCR cycles were 95 °C for 15 s
and 60 °C for 1 min, and the dissociation curve was
constructed by increasing temperatures from 60 to
90 °C. Viral copies were determined by qPCR, as
described above. A standard curve from a previous
established virus stock was serially diluted to con-
struct a standard curve, and viral copies were de-
termined from each sample analyzed; results were
expressed as viral copies in the brain per 100 mg/tissue.
Primers used for cytokine quantification are listed in
Table 1.
Viral titration
Viral stocks were titrated by the PFU assay. Briefly, Vero
cells were cultivated in 24-well plates, and cell-confluent
monolayers were infected with 100 μl of serial dilutions of
the viral stocks. Next, the cells were incubated for 1.5 h at
37 °C and washed with PBS, and an overlay consisting of
DMEM containing 2 % fetal bovine serum and 3 %
carboxymethylcellulose was added to the wells. The
cells were then incubated for 7 days at 37 °C/5 %CO2.
After this period of incubation, the overlay was dis-
carded and the cells were washed with PBS and
stained with 0.5 % Neutral Red solution. The viral titer
was based on the number of plaques present in the
highest dilution.
Cytokine quantification ELISA
Serum samples were used to quantify the levels of
IFN-γ and TNF-α using commercial kits (R&D Sys-
tems, Abingdon, UK). ELISA was performed by coat-
ing 96-well polystyrene microtiter plates with the
specific antibody. After blocking, standards and sam-
ples were and the plates were incubated overnight at
4 °C. A specific biotinylated antibody was added to
all wells and incubated for 1 h at room temperature.
The plates were washed and incubated for 30 min with
horseradish peroxidase-conjugated streptavidin. 3-3′,5,5′-
tetramethylbenzidine (TMB) substrate reagent solution
(Sigma-Aldrich) was added to the wells. Absorbance
was read at 450 nm.
Flow cytometry
Mice were perfused with PBS before the brains were har-
vested. Brain tissues were pretreated with 2 μg/ml collage-
nase D and 1 μg/ml DNAse I (both Roche Diagnostics),
and total cells were isolated by cell straining (100-μm
mesh). Brain homogenates were separated into neuronal
and leukocyte populations by discontinuous density gradi-
ent centrifugation using isotonic Percoll (GE HealthCare,
Uppsala, Sweden) as described by Pino and Cardona [40].
After isolation, cells were stimulated in vitro with PMA
and Ionomycin plus BD GolgiStop™ (BD Biosciences, San
Jose, CA, USA) for at least 4 h at 37 °C. After stimulation,
the cells were fixed with BD Cytofix/Cytoperm™ Plus
Fixation/Permeabilization Kit and intracellular staining
was carried out following the manufacturer’s instructions
(BD Biosciences). Flow cytometry was performed using a
FACS Verse (BD Biosciences) with the specific antibodies
listed: anti-CD45 clone A20, anti-CD4 clone GK1.5, CD8α
clone 5H10-1, IFN-γ clone XMG1.2, TNF-α clone MP6-
XT22, CD3 clone 17A2, IL-10 clone JES5-16E3, F4/80
clone BM8 (all from BioLegend Inc., San Diego, CA,
USA), IL-33 clone 396118 (R&D Systems, Minneapolis,
MN, USA), and anti-iNOS (NOS2) clone N-20 (Santa
Cruz Biotechnology, San Diego, CA, USA).
Table 1 Primers used for gene expression analysis
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Statistical analysis
The data are reported as the means ± SEM. Student’s t test
was used to test for statistical significance of the differ-
ences between the different group parameters. p values of
less than 0.05 were considered statistically significant.
When necessary, statistical analysis was performed by
either one-way ANOVA or two-way ANOVA with
Bonferroni post-test as stated on figure legends.
Additional file
Additional file 1: Figure S1. Phenotypic profile of CNS-infiltrating cells
on Stat6−/− mice. Figure S2. Stat6−/− mice survival after ROCV infection.
Figure S3. Cytokine profile on Stat6−/− mice. Figure S4. Effect of ROCV
infection on transaminases and urea profile on WT, ST2−/−, and Stat6−/− mice.
Figure S5. Nitric oxide deficiency leads to increased histopathological
score on CNS ROCV-induced encephalitis. Figure S6. Gating strategy
for macrophage F4/80+ cell analysis.
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